These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 17200247

  • 21. Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.
    Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.
    J Infect Dis; 2005 Nov 15; 192(10):1720-6. PubMed ID: 16235169
    [Abstract] [Full Text] [Related]

  • 22. Economic evaluation of Haemophilus influenzae type B vaccination in Indonesia: a cost-effectiveness analysis.
    Broughton EI.
    J Public Health (Oxf); 2007 Dec 15; 29(4):441-8. PubMed ID: 17875589
    [Abstract] [Full Text] [Related]

  • 23. A cost-effectiveness analysis of universal childhood hepatitis A vaccination in China.
    Zhuang GH, Pan XJ, Wang XL.
    Vaccine; 2008 Aug 18; 26(35):4608-16. PubMed ID: 18597903
    [Abstract] [Full Text] [Related]

  • 24. Cost-effectiveness of pneumococcal conjugate vaccine: evidence from the first 5 years of use in the United States incorporating herd effects.
    Ray GT, Whitney CG, Fireman BH, Ciuryla V, Black SB.
    Pediatr Infect Dis J; 2006 Jun 18; 25(6):494-501. PubMed ID: 16732146
    [Abstract] [Full Text] [Related]

  • 25. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
    Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B.
    Vaccine; 2006 Nov 17; 24(47-48):6980-9. PubMed ID: 16860909
    [Abstract] [Full Text] [Related]

  • 26. A mathematical model of hepatitis a transmission in the United States indicates value of universal childhood immunization.
    Van Effelterre TP, Zink TK, Hoet BJ, Hausdorff WP, Rosenthal P.
    Clin Infect Dis; 2006 Jul 15; 43(2):158-64. PubMed ID: 16779741
    [Abstract] [Full Text] [Related]

  • 27. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States.
    Arguedas MR, Heudebert GR, Fallon MB, Stinnett AA.
    Am J Gastroenterol; 2002 Mar 15; 97(3):721-8. PubMed ID: 11922569
    [Abstract] [Full Text] [Related]

  • 28. The cost-effectiveness of vaccinating chronic hepatitis C patients against hepatitis A.
    Jacobs RJ, Koff RS, Meyerhoff AS.
    Am J Gastroenterol; 2002 Feb 15; 97(2):427-34. PubMed ID: 11866283
    [Abstract] [Full Text] [Related]

  • 29. [Vaccination--value for money?].
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Kristiansen IS.
    Tidsskr Nor Laegeforen; 2006 Oct 19; 126(20):2670-3. PubMed ID: 17057767
    [Abstract] [Full Text] [Related]

  • 30. The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.
    Rein DB, Weinbaum CM.
    Vaccine; 2008 Oct 03; 26(42):5331-3. PubMed ID: 18706957
    [Abstract] [Full Text] [Related]

  • 31. Enhanced decision support for policy makers using a web interface to health-economic models--illustrated with a cost-effectiveness analysis of nation-wide infant vaccination with the 7-valent pneumococcal conjugate vaccine in the Netherlands.
    Hubben GA, Bos JM, Glynn DM, van der Ende A, van Alphen L, Postma MJ.
    Vaccine; 2007 May 04; 25(18):3669-78. PubMed ID: 17360082
    [Abstract] [Full Text] [Related]

  • 32. Cost-utility of universal hepatitis A vaccination in Canada.
    Bauch CT, Anonychuk AM, Pham BZ, Gilca V, Duval B, Krahn MD.
    Vaccine; 2007 Dec 12; 25(51):8536-48. PubMed ID: 17996339
    [Abstract] [Full Text] [Related]

  • 33. Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.
    Kim SY, Billah K, Lieu TA, Weinstein MC.
    Am J Prev Med; 2006 Jun 12; 30(6):498-506. PubMed ID: 16704944
    [Abstract] [Full Text] [Related]

  • 34. Impact of hepatitis A vaccination on health care utilization in the United States, 1996-2004.
    Zhou F, Shefer A, Weinbaum C, McCauley M, Kong Y.
    Vaccine; 2007 May 04; 25(18):3581-7. PubMed ID: 17306908
    [Abstract] [Full Text] [Related]

  • 35. Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.
    Chapko MK, Yee HS, Monto A, Dominitz JA.
    Vaccine; 2010 Feb 17; 28(7):1726-31. PubMed ID: 20044051
    [Abstract] [Full Text] [Related]

  • 36. Medicaid-based child restraint system disbursement and education and the vaccines for children program: comparative cost-effectiveness.
    Goldstein JA, Winston FK, Kallan MJ, Branas CC, Schwartz JS.
    Ambul Pediatr; 2008 Feb 17; 8(1):58-65. PubMed ID: 18191783
    [Abstract] [Full Text] [Related]

  • 37. Quantifying the impact of hepatitis A immunization in the United States, 1995-2001.
    Samandari T, Bell BP, Armstrong GL.
    Vaccine; 2004 Oct 22; 22(31-32):4342-50. PubMed ID: 15474727
    [Abstract] [Full Text] [Related]

  • 38. Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.
    Chodick G, Waisbourd-Zinman O, Shalev V, Kokia E, Rabinovich M, Ashkenazi S.
    Eur J Public Health; 2009 Jun 22; 19(3):254-9. PubMed ID: 19221026
    [Abstract] [Full Text] [Related]

  • 39. Evaluating the benefits of increasing measles immunization rates.
    Zwanziger J, Szilagyi PG, Kaul P.
    Health Serv Res; 2001 Oct 22; 36(5):885-909. PubMed ID: 11666109
    [Abstract] [Full Text] [Related]

  • 40. Projected cost-effectiveness of rotavirus vaccination for children in Asia.
    Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.
    J Infect Dis; 2005 Sep 01; 192 Suppl 1():S133-45. PubMed ID: 16088797
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.